The AWS Kiro team today is announcing v2.0, which delivers a headless mode, Windows support and an updated, refreshed user ...

AWS announced the launch of its AI bio tool, Amazon Bio Discovery, to accelerate the early-stage process of drug discovery.

As enterprises struggle to govern rapidly multiplying AI agents, AWS is offering a centralized registry to bring visibility, ownership, and lifecycle control.

A new agentic AI application aims to speed up drug development, helping bring new medical treatments to patients faster.

AWS Graviton chips deliver leading price performance and energy efficiency for applications running in the cloud. Graviton ...